Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Hypersensitivity Reaction

  Free Subscription


Articles published in Acta Derm Venereol

Retrieve available abstracts of 84 articles:
HTML format



Single Articles


    February 2024
  1. AKAI N, Hashimoto T, Okuzawa M, Okuno S, et al
    Lesional Infiltration of Eosinophils, Basophils, and M2 Macrophages Expressing Eotaxin-1 and Eotaxin-3 in Granuloma Faciale, but not in Erythema Elevatum Diutinum.
    Acta Derm Venereol. 2024;104:adv35401.
    PubMed    


  2. CORK MJ, Lockshin B, Pinter A, Chen Z, et al
    Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator's Global Assessment: A Post Hoc Analysis of a P
    Acta Derm Venereol. 2024;104:adv13467.
    PubMed     Abstract available


  3. KAMPHUIS E, Boesjes CM, Loman L, Kamsteeg M, et al
    Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry.
    Acta Derm Venereol. 2024;104:adv19454.
    PubMed     Abstract available


    January 2024
  4. VITTRUP I, Thein D, Thomsen SF, Egeberg A, et al
    Risk Factors that Impact Treatment with Oral Janus Kinase Inhibitors Among Adult Patients with Atopic Dermatitis: A Nationwide Registry Study.
    Acta Derm Venereol. 2024;104:adv18638.
    PubMed     Abstract available


  5. PESQUE D, Ciudad A, Andrades E, Soto D, et al
    Solar Urticaria: An Ambispective Study in a Long-term Follow-up Cohort with Emphasis on Therapeutic Predictors and Outcomes.
    Acta Derm Venereol. 2024;104:adv25576.
    PubMed     Abstract available


    December 2023
  6. MAURELLI M, Chiricozzi A, Peris K, Gisondi P, et al
    Atopic Dermatitis in the Elderly Population.
    Acta Derm Venereol. 2023;103:adv13363.
    PubMed     Abstract available


  7. HOPKINS K, Antelmi A, Dahlin J, Olsson K, et al
    Increased Rates of Gold and Acrylate Allergy in Individuals with Fibromyalgia Tested with an Extended Dental Patch Test Series.
    Acta Derm Venereol. 2023;103:adv22336.
    PubMed     Abstract available


  8. HAMNERIUS N, Dahlin J, Bruze M, Nilsson K, et al
    Colophonium-related Allergic Contact Dermatitis Caused by Medical Adhesive Tape Used to Prevent Skin Lesions in Soldiers.
    Acta Derm Venereol. 2023;103:adv18428.
    PubMed     Abstract available


    November 2023
  9. SPRING P
    Botanical Extract Coacillium for Management of Paediatric Atopic Dermatitis: A Case Report.
    Acta Derm Venereol. 2023;103:adv13376.
    PubMed    


  10. PEREYRA-RODRIGUEZ JJ, Baldrich ES, Ruiz-Villaverde R, Torres EB, et al
    Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus.
    Acta Derm Venereol. 2023;103:adv12314.
    PubMed     Abstract available


  11. GIL TY, Jin BR, Park YJ, Kim HM, et al
    Effects of Magnoliae Flos on Atopic Dermatitis-Like Inflammation Evaluated via Extracellular Signal-regulated Kinase or Signal Transducers and Activators of Transcription 1/3 Signalling Pathways.
    Acta Derm Venereol. 2023;103:adv11593.
    PubMed     Abstract available


    October 2023
  12. SUGIYAMA A, Murakami Y, Okamoto K, Nakano H, et al
    Nocturnal Scratching and Quality of Sleep in Children with Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv12345.
    PubMed     Abstract available


  13. REGUIAI Z, Becherel PA, Perrot JL, Fougerousse AC, et al
    Impact of Baricitinib on Patients' Quality of Life after One Year of Treatment for Atopic Dermatitis in Real-World Practice: Results of the Observatory of Chronic Inflammatory Skin Diseases Registry.
    Acta Derm Venereol. 2023;103:adv14153.
    PubMed     Abstract available


  14. YASUDA KI, Ishiuji Y, Ebata T, Kogure T, et al
    Monitoring Sleep and Scratch Improves Quality of Life in Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv11922.
    PubMed     Abstract available


    September 2023
  15. WU Z, Zhang W, Wu C, Zhou K, et al
    Hyperpigmentation in an Elderly Patient with Atopic Dermatitis: A Quiz.
    Acta Derm Venereol. 2023;103:adv13351.
    PubMed     Abstract available


    August 2023
  16. KIM MJ, Kim BR, Kim SH, Chang YS, et al
    Clinical Response to Low-dose Omalizumab Treatment in Chronic Spontaneous Urticaria: A Retrospective Study of 179 Patients.
    Acta Derm Venereol. 2023;103:adv11627.
    PubMed     Abstract available


  17. PAVLENKO D, Todurga Seven Z, Bystrom L, Markan A, et al
    Crisaborole Inhibits Itch and Pain by Preventing Neutrophil Infiltration in a Mouse Model of Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv13382.
    PubMed     Abstract available


  18. ZHANG J, Loman L, Oldhoff JM, Schuttelaar MLA, et al
    Beyond Anxiety and Depression: Loneliness and Psychiatric Disorders in Adults with Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv9378.
    PubMed     Abstract available


    July 2023
  19. KURKI M, Sinikumpu SP, Kiviniemi E, Jokelainen J, et al
    Validation of Diagnoses of Atopic Dermatitis in Hospital Registries: A Cross-sectional Database Study from Finland.
    Acta Derm Venereol. 2023;103:adv7266.
    PubMed    


    June 2023
  20. SZABO L, Kapitany A, Somogyi O, Alhafez I, et al
    Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv9413.
    PubMed     Abstract available


  21. KUPSA R, Gruber-Wackernagel A, Hofer A, Quehenberger F, et al
    Narrowband-ultraviolet B vs Broadband-ultraviolet B in Treatment of Chronic Pruritus: A Randomized, Single-blinded, Non-inferiority Study.
    Acta Derm Venereol. 2023;103:adv9403.
    PubMed     Abstract available


  22. MISERY L, Seneschal J, Corgibet F, Halioua B, et al
    Impact of Atopic Dermatitis on Patients and their Partners.
    Acta Derm Venereol. 2023;103:adv5285.
    PubMed     Abstract available


  23. GRINICH EE, Thibau IJ, Latour E, Price KN, et al
    Factors Associated with Eczema Clinical Trial Awareness, Interest, and Participation in Adults.
    Acta Derm Venereol. 2023;103:adv6520.
    PubMed     Abstract available


    May 2023
  24. HARDER I, Stolzl D, Sander N, Hartmann J, et al
    Effects of Early Emollient Use in Children at High Risk of Atopic Dermatitis: A German Pilot Study.
    Acta Derm Venereol. 2023;103:adv5671.
    PubMed     Abstract available


  25. LEE GW, Kim K, Kim SJ, Shin K, et al
    Therapeutic Effect of Dupilumab on Systemic and Vascular Inflammation in Adults with Severe Atopic Dermatitis: Feasibility Study Using 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography.
    Acta Derm Venereol. 2023;103:adv5320.
    PubMed     Abstract available


    April 2023
  26. TANJI T, Watabe D, Arakawa N, Kamada H, et al
    Dual Interleukin-4/Interleukin-13 Blocker-induced Arthralgia Treated Successfully with Upadacitinib in a Patient with Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv5326.
    PubMed    


  27. WOO YR, Cho M, Han KD, Cho SH, et al
    Increased Risk of Dementia in Patients with Atopic Dermatitis: A Nationwide Population-Based Cohort Study.
    Acta Derm Venereol. 2023;103:adv4557.
    PubMed     Abstract available


  28. DE BRUIN-WELLER M, Deleuran M, Biedermann T, Bissonnette R, et al
    The Treat-to-Target Project in Atopic Dermatitis: One Year On.
    Acta Derm Venereol. 2023;103:adv5382.
    PubMed     Abstract available


  29. ALSTERHOLM M, Svedbom A, Anderson CD, Holm Sommar L, et al
    Establishment and Utility of SwedAD: A Nationwide Swedish Registry for Patients with Atopic Dermatitis Receiving Systemic Pharmacotherapy.
    Acta Derm Venereol. 2023;103:adv7312.
    PubMed     Abstract available


  30. MANDELIN JM, Ekman A, Ruohonen ST, Korhonen L, et al
    Atopic Dermatitis Patients' Preference on Patient Self-administered Tools Used in Clinical Practice.
    Acta Derm Venereol. 2023;103:adv5261.
    PubMed    


  31. SCHLACHTER S, Sommer R, Augustin M, Tsianakas A, et al
    A Comparative Analysis of the Predictors, Extent and Impacts of Self-stigma in Patients with Psoriasis and Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv3962.
    PubMed     Abstract available


    March 2023
  32. BELFRAGE E, Jinnestal CL, Jonsen A, Bengtsson A, et al
    Role of Mannose-binding Lectin and Association with Microbial Sensitization in a Cohort of Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv2405.
    PubMed     Abstract available


  33. ALBERS CC, Metze D, Steinbrink K, Bohm M, et al
    Systemic Sarcoidosis with Cutaneous Tattoo Involvement Following COVID-19 Vaccination.
    Acta Derm Venereol. 2023;103:adv6244.
    PubMed    


  34. KIISKI V, Ukkola-Vuoti L, Vikkula J, Ranta M, et al
    Effect of Disease Severity on Comorbid Conditions in Atopic Dermatitis: Nationwide Registry-Based Investigation in Finnish Adults.
    Acta Derm Venereol. 2023;103:adv00882.
    PubMed     Abstract available


  35. ACHTEN R, Van der Rijst L, Piena M, Lamers H, et al
    Economic and Humanistic Burden in Paediatric Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2023;103:adv00881.
    PubMed     Abstract available


  36. FORER E, Golan Tripto I, Bari R, Shaki D, et al
    Effect of Paediatric Atopic Dermatitis on Parental Sleep Quality.
    Acta Derm Venereol. 2023;103:adv00879.
    PubMed     Abstract available


    February 2023
  37. BOESJES CM, Van der Gang LF, Zuithoff NPA, Bakker DS, et al
    Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry.
    Acta Derm Venereol. 2023;103:adv00872.
    PubMed     Abstract available


  38. HAN Y, Woo YR, Cho SH, Lee JD, et al
    Itch and Janus Kinase Inhibitors.
    Acta Derm Venereol. 2023;103:adv00869.
    PubMed     Abstract available


  39. LEE EM, Cho YT, Chan TC, Shen D, et al
    Economic Burden of Atopic Dermatitis in Taiwan.
    Acta Derm Venereol. 2023;103:adv00866.
    PubMed     Abstract available


  40. TAWIL S, Irani C, Kfoury R, Abramian S, et al
    Association of Chronic Urticaria with Psychological Distress: A Multicentre Cross-sectional Study.
    Acta Derm Venereol. 2023;103:adv00865.
    PubMed     Abstract available


    January 2023
  41. WEISSHAAR E, Bentz P, Apfelbacher C, Haufe E, et al
    Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany.
    Acta Derm Venereol. 2023;103:adv00854.
    PubMed     Abstract available


  42. BARLOW R, Payyazhi G, Hogan S, Grindlay D, et al
    Suicide and Suicidality in Children and Adolescents with Chronic Skin Disorders: A Systematic Review.
    Acta Derm Venereol. 2023;103:adv00851.
    PubMed     Abstract available


  43. LEE HJ, Lee GN, Lee JH, Han JH, et al
    Psychological Stress in Parents of Children with Atopic Dermatitis: A Cross-sectional Study from the Korea National Health and Nutrition Examination Survey.
    Acta Derm Venereol. 2023;103:adv00844.
    PubMed     Abstract available


    December 2022
  44. AUGUSTIN M, Costanzo A, Pink A, Seneschal J, et al
    Real-World Treatment Patterns and Treatment Benefits among Adult Patients with Atopic Dermatitis: Results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey.
    Acta Derm Venereol. 2022;102:adv00830.
    PubMed     Abstract available


    November 2022
  45. BOESJES CM, Kamphuis E, Zuithoff NPA, Bakker DS, et al
    Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry.
    Acta Derm Venereol. 2022;102:adv00820.
    PubMed     Abstract available


  46. TIZEK L, Wecker H, Schneider S, Johansson EK, et al
    Eczema-related Web Search Data in Sweden: Investigating Search Patterns and the Influence of Weather.
    Acta Derm Venereol. 2022;102:adv00810.
    PubMed     Abstract available


  47. KIM DC, Choi YW, Lee ES, Choi JW, et al
    No Association Between First Exposure to General Anaesthesia and Atopic Dermatitis in the Paediatric Population.
    Acta Derm Venereol. 2022 Nov 1. doi: 10.2340/actadv.v102.2738.
    PubMed     Abstract available


    October 2022
  48. MERHAND S, Thenie C, Taieb C
    Family Impact of Atopic Dermatitis in Children Under Six Years of Age: A French Evaluation.
    Acta Derm Venereol. 2022 Oct 25. doi: 10.2340/actadv.v102.2562.
    PubMed    


  49. JWO JY, Chiou K, Tsai J, Huang YC, et al
    Efficacy of Acupuncture for Treatment of Atopic Eczema and Chronic Eczema: A Systematic Review and Meta-analysis.
    Acta Derm Venereol. 2022;102:adv00791.
    PubMed    


  50. IVERT LU, Svedbom A, Lundqvist M, Wahlgren CF, et al
    The Impact of Systemic Treatment for Atopic Dermatitis on Depressive Symptoms: A Prospective Clinical Cohort Study.
    Acta Derm Venereol. 2022 Oct 3. doi: 10.2340.
    PubMed     Abstract available


  51. BRADLEY M, Svensson A
    Increased Knowledge-based Care is Indicated for Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2022 Oct 3. doi: 10.2340/actadv.v102.4576.
    PubMed    


    September 2022
  52. LUHERNE C, Menguy S, Ferte T, Beylot-Barry M, et al
    A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sezary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma.
    Acta Derm Venereol. 2022;102:adv00773.
    PubMed     Abstract available


    August 2022
  53. MOSE AP, Adwa U, Svedman C
    Allergic Contact Dermatitis to Topical Clindamycin in a Patient with Hidradenitis Suppurativa.
    Acta Derm Venereol. 2022 Aug 16. doi: 10.2340/actadv.v102.3425.
    PubMed    


    July 2022
  54. JOHANSSON EK, Brenneche A, Trangbaek D, Stelmaszuk MN, et al
    Treatment Patterns among Patients with Atopic Dermatitis in Secondary Care: A National, Observational, Non-interventional, Retrospective Study in Sweden.
    Acta Derm Venereol. 2022 Jul 11. doi: 10.2340/actadv.v102.1986.
    PubMed     Abstract available


  55. SEDEH FB, Henning MAS, Jemec GBE, Ibler KS, et al
    Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis.
    Acta Derm Venereol. 2022 Jul 11. doi: 10.2340/actadv.v102.2075.
    PubMed     Abstract available


  56. OLESEN CM, Clausen ML, Agner T, Asplund M, et al
    Altered Maturation of the Skin Bacterial Communities in Infants with Atopic Dermatitis.
    Acta Derm Venereol. 2022 Jul 11. doi: 10.2340/actadv.v102.2275.
    PubMed     Abstract available


    June 2022
  57. SANCHEZ-DIAZ M, Salazar-Nievas MC, Molina-Leyva A, Arias-Santiago S, et al
    Type D Personality Is Associated with Poorer Quality of Life in Patients with Chronic Spontaneous Urticaria: A Cross-sectional Study.
    Acta Derm Venereol. 2022;102:adv00734.
    PubMed     Abstract available


  58. HEDEGAARD PLIESS LARSEN H, Vittrup I, Frier Ruge I, Elberling J, et al
    Severe and ChRonic ATopic Dermatitis CoHort (SCRATCH): A Danish Real-world Evidence Atopic Dermatitis Treatment Registry.
    Acta Derm Venereol. 2022 Jun 7. doi: 10.2340.
    PubMed     Abstract available


  59. WANG M, Zheng Q, Tang S, Shen F, et al
    Purpuric Drug Eruption in a Patient with Atopic Dermatitis Treated with Dupilumab.
    Acta Derm Venereol. 2022 Jun 7. doi: 10.2340/actadv.v102.2245.
    PubMed    


  60. SALAVA A, Rieppo R, Lauerma A, Salo V, et al
    Age-dependent Distribution of Atopic Dermatitis in Primary Care: A Nationwide Population-based Study from Finland.
    Acta Derm Venereol. 2022 Jun 7. doi: 10.2340/actadv.v102.2287.
    PubMed     Abstract available


  61. WU L, Ali K, Qiu Y, Li M, et al
    Dupilumab-induced Acute Generalized Exanthematous Pustulosis in a 17-year-old Female Chinese Patient with Atopic Dermatitis.
    Acta Derm Venereol. 2022 Jun 7. doi: 10.2340/actadv.v102.1079.
    PubMed    


    May 2022
  62. OSAWA K, Kiniwa Y, Shimosato Y, Midorikawa H, et al
    Toxic Epidermal Necrolysis Caused by Apalutamide: A Case Report of Treatment Using Etanercept with Conventional Steroid Therapy.
    Acta Derm Venereol. 2022;102:adv00723.
    PubMed    


  63. MIYAMOTO S, Imai Y, Natsuaki M, Yamanishi K, et al
    Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab.
    Acta Derm Venereol. 2022 May 17. doi: 10.2340.
    PubMed    


    April 2022
  64. GERNER T, Rasmussen Rinnov M, Halling AS, Haarup Ravn N, et al
    Differences in Occurrence, Risk Factors and Severity of Early-onset Atopic Dermatitis among Preterm and Term Children.
    Acta Derm Venereol. 2022 Apr 26. doi: 10.2340.
    PubMed     Abstract available


  65. WOLLENBERG A, Marcoux D, Silverberg J, Aoki V, et al
    Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2022 Apr 8. doi: 10.2340.
    PubMed     Abstract available


  66. THOMSEN SF, Pritzier EC, Anderson CD, Juvik S, et al
    Treatment Patterns and Clinical Outcomes of Chronic Urticaria: Two-year Follow-up Results from the Scandinavian AWARE Study.
    Acta Derm Venereol. 2022;102:adv00689.
    PubMed     Abstract available


    March 2022
  67. LUNDIN S, Bergstrom A, Wahlgren CF, Johansson EK, et al
    Living with Atopic Dermatitis as a Young Adult in Relation to Health-related Quality of Life and Healthcare Contacts: A Population-based Study.
    Acta Derm Venereol. 2022 Mar 21. doi: 10.2340.
    PubMed     Abstract available


  68. CREPY MN, Bensefa-Colas L, Aubin F, Simon M, et al
    Vocational Guidance for Young Atopic Dermatitis Patients: A Survey of Physicians' Opinions and Practices.
    Acta Derm Venereol. 2022 Mar 1. doi: 10.2340.
    PubMed     Abstract available


    February 2022
  69. BATINAC T, Hlaca N, Simetic L, Valkovic F, et al
    Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma.
    Acta Derm Venereol. 2022;102:adv00650.
    PubMed    


    January 2022
  70. ACHTEN RE, Van Luijk C, Van der Rijst L, Bakker D, et al
    Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis.
    Acta Derm Venereol. 2022 Jan 31. doi: 10.2340/actadv.v101.1128.
    PubMed     Abstract available


  71. KIYOHARA T, Fukudome T, Kamio Y, Koike Y, et al
    Clinical Course of Atopic Dermatitis in an Adult with Amyotrophic Lateral Sclerosis: Etiologic Implications of Voluntary Movements and Dermatitis Severity.
    Acta Derm Venereol. 2022 Jan 28. doi: 10.2340/actadv.v101.1121.
    PubMed    


  72. ROGNER D, Biedermann T, Lauffer F
    Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience.
    Acta Derm Venereol. 2022 Jan 27. doi: 10.2340/actadv.v101.1088.
    PubMed    


  73. TAYEFI M, Bradley M, Neijber A, Fastberg A, et al
    Chronic Urticaria: A Swedish Registry-based Cohort Study on Population, Comorbidities and Treatment Characteristics.
    Acta Derm Venereol. 2022;102:adv00624.
    PubMed     Abstract available


    December 2021
  74. HUPPOP F, Dahnhardt-Pfeiffer S, Folster-Holst R
    Characterization of Classical Flexural and Nummular Forms of Atopic Dermatitis in Childhood with Regard to Anamnestic, Clinical and Epidermal Barrier Aspects.
    Acta Derm Venereol. 2021 Dec 22. doi: 10.2340.
    PubMed     Abstract available


  75. QIU Y, Ali K, Lou H, Shan J, et al
    Successful Treatment of Atopic Dermatitis with Dupilumab in a Patient with Non-Hodgkin's Lymphoma.
    Acta Derm Venereol. 2021 Dec 14. doi: 10.2340.
    PubMed    


  76. JU Y, Li M, Lu X, Zhao C, et al
    Skin Picking in Atopic Dermatitis and Psoriasis Patients: A Single-centre Cross-sectional Study in China.
    Acta Derm Venereol. 2021 Dec 14. doi: 10.2340.
    PubMed    


    November 2021
  77. STAUMONT D, Taieb C, Merhand S, Shourick J, et al
    The Atopic Dermatitis Control Tool, A High-Performance Tool for Optimal Support.
    Acta Derm Venereol. 2021 Nov 29. doi: 10.2340.
    PubMed     Abstract available


  78. MITRI F, Toberer F, Enk AH, Hartmann M, et al
    Acute Generalized Exanthematous Pustulosis in Close Temporal Association with mRNA-1273 Vaccine.
    Acta Derm Venereol. 2021;101:adv00596.
    PubMed    


  79. NYMAN GSA, Gimenez-Arnau AM, Grigaitiene J, Malinauskiene L, et al
    Patch Testing with Propolis of Different Geographical Origins in a Baseline Series.
    Acta Derm Venereol. 2021;101:adv00591.
    PubMed     Abstract available


    October 2021
  80. KWIATKOWSKA D, Reich A
    Role of Mast Cells in the Pathogenesis of Pruritus in Mastocytosis.
    Acta Derm Venereol. 2021;101:adv00583.
    PubMed     Abstract available


  81. NAKAHARA T, Kido-Nakahara M, Onozuka D, Sakai S, et al
    Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study.
    Acta Derm Venereol. 2021 Oct 28. doi: 10.2340.
    PubMed    


  82. TAKEOKA S, Kamata M, Yokoi I, Takehara A, et al
    Rapid Enlargement of Vitiligo Vulgaris after Initiation of Dupilumab for Atopic Dermatitis: A Case Report.
    Acta Derm Venereol. 2021;101:adv00581.
    PubMed    


  83. SILVERBERG JI, Simpson EL, Boguniewicz M, De Bruin-Weller MS, et al
    Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis.
    Acta Derm Venereol. 2021 Oct 7. doi: 10.2340.
    PubMed     Abstract available


    September 2021
  84. WEISS D, Nordhorn I, Tizek L, Werfel T, et al
    Prescription Behaviour and Barriers to Prescription of Biologicals for Treatment of Chronic Inflammatory Skin Diseases in Dermatological Practice in Two German Federal States.
    Acta Derm Venereol. 2021;101:adv00560.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.